Not sure why anyone would buy it though. If you replace the board and the new management there might be some chance to save it - but it's probably too far gone now.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025